Published in Arch Mal Coeur Vaiss on July 01, 1990
Doctors record higher blood pressures than nurses: systematic review and meta-analysis. Br J Gen Pract (2014) 1.91
Renal artery stent placement: long-term results with the Wallstent endoprosthesis. Radiology (1994) 1.43
Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens (2001) 1.29
Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int (2000) 1.27
User procedure for self-measurement of blood pressure. First International Consensus Conference on Self Blood Pressure Measurement. Blood Press Monit (2000) 1.01
Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res (1992) 0.99
Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab (2008) 0.98
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline. Lancet (1993) 0.86
Evaluation of oral health related to body mass index. Oral Dis (2012) 0.84
Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis. Kidney Int (1997) 0.84
Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force). J Nutr Health Aging (2008) 0.80
[Prevalence, treatment and control of hypertension in family practice patients in France during 1994]. Arch Mal Coeur Vaiss (1996) 0.79
[Ambulatory blood pressure in hypertension with dysautonomia]. Arch Mal Coeur Vaiss (1990) 0.79
Parkinson's disease and hypertension: chronic bromocriptine treatment. Neurology (1985) 0.78
Platelet alpha 2- and leucocyte beta 2-adrenoceptors in phaeochromocytoma: effect of tumour removal. Eur J Clin Invest (1988) 0.78
Non-invasive ambulatory blood pressure variability and cardiac baroreflex sensitivity. J Hypertens (1995) 0.78
Should pulse pressure and day/night variations in blood pressure be seen as independent risk factors requiring correction or simply as markers to be taken into account when evaluating overall vascular risk? Diabetes Metab (2007) 0.78
Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril. Am J Hypertens (1998) 0.78
[Does selective inhibition of prostaglandins exist? Apropos of hyponatremia with sulindac]. Presse Med (1988) 0.77
[Pulmonary embolism in patients using estrogen-progestagen contraceptives]. Presse Med (1998) 0.77
Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study. Heart (2002) 0.77
[Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?]. Arch Mal Coeur Vaiss (2003) 0.77
Excretion mass balance evaluation, metabolite profile analysis and metabolite identification in plasma and excreta after oral administration of [14C]-meloxicam to the male cat: preliminary study. J Vet Pharmacol Ther (2010) 0.77
[Usefulness of a percutaneous endoprosthesis in the treatment of renal artery stenoses]. Arch Mal Coeur Vaiss (1989) 0.76
[Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study]. Rev Med Interne (1989) 0.76
Domperidone in the management of orthostatic hypotension. Clin Neuropharmacol (1985) 0.75
[Cataract and simvastatin: case report]. Therapie (1999) 0.75
Evaluation of aortic stiffness to predict and prevent the risk of atrial fibrillation in hypertensive patients in their 50's. Arch Cardiovasc Dis (2008) 0.75
Influence of glucose metabolism on nycthemeral blood pressure variability in hypertensives with an elevated waist-hip ratio. A link with arterial distensibility. Am J Hypertens (1995) 0.75
[Arterial hypertension management in general practice in France according to global risk factors]. Arch Mal Coeur Vaiss (2001) 0.75
[Results of the evaluation of platelet sodium-proton exchange in the young hypertensive subject]. Arch Mal Coeur Vaiss (1991) 0.75
[Clinical pharmacology and bases of the treatment of orthostatic hypotension]. Therapie (1987) 0.75
[Blood pressure control after acute coronary events. Results of the PREVENIR study]. Arch Mal Coeur Vaiss (2001) 0.75
[Arterial hypertension with orthostatic hypotension caused by dysregulation of the baroreflex. Correction with domperidone and verapamil]. Presse Med (1986) 0.75
[How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution]. Arch Mal Coeur Vaiss (1984) 0.75
[Significance of the modern technics of artificial feeding in the treatment of severe acute peritonitis]. Anesth Analg (Paris) (1977) 0.75
[Water intoxication attributed to haloperidol]. Nouv Presse Med (1981) 0.75
[Value of nocturnal blood pressure in treated non-insulin-dependent hypertensive patients]. Arch Mal Coeur Vaiss (1992) 0.75
[Reno-vascular arterial hypertension successfully treated by means of percutaneous transluminal angioplasty]. Nouv Presse Med (1980) 0.75
[Conceptual basis and diagnosis of primary hyperaldosteronism]. Arch Mal Coeur Vaiss (1995) 0.75
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates]. Arch Mal Coeur Vaiss (1984) 0.75
[Percutaneous transluminal angioplasty in atheromatous stenosis of the renal artery. Late results]. Arch Mal Coeur Vaiss (1986) 0.75
[Value of the study of circulating adrenergic receptors in the diagnosis and surveillance after surgery of pheochromocytoma]. Arch Mal Coeur Vaiss (1988) 0.75
[Microalbuminuria, pulse wave velocity and common carotid artery intima-media thickness in type 2 diabetes]. Arch Mal Coeur Vaiss (2001) 0.75
9B.07: EFFECT OF POSTURAL CHANGES ON ALDOSTERONE TO PLASMA RENIN RATIO IN PATIENTS WITH SUSPECTED SECONDARY HYPERTENSION. J Hypertens (2015) 0.75
Prevention of stress-induced hypertension in hypertensive patients. J Cardiovasc Pharmacol (1990) 0.75
[Should arterial hypertension in sleep apnea syndrome be stressed?]. Arch Mal Coeur Vaiss (1991) 0.75
[Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]. Arch Mal Coeur Vaiss (1989) 0.75
[Ambulatory blood pressure in the young adult with hypertension history during childhood]. Arch Mal Coeur Vaiss (1991) 0.75
[Antihypertensive therapy with a single daily dose of sotalol]. Sem Hop (1982) 0.75
[Competitive inhibitors of angiotensin II]. Therapie (1981) 0.75
[Systolic blood pressures are not comparable when home blood pressure is measured with a wrist or an arm validated monitor]. Arch Mal Coeur Vaiss (2005) 0.75
[Intima media thickness of the carotid artery in white coat and ambulatory hypertension]. Arch Mal Coeur Vaiss (1997) 0.75
[Arterial pseudo-hypertension]. Rev Prat (1988) 0.75
Nycthemeral blood pressure variability in obstructive sleep apnea syndrome: relationship to left ventricular hypertrophy and metabolic disorders. J Hypertens Suppl (1993) 0.75
[Comparison and criteria of choice of various beta-blockaders prescribed as antihypertensive agents]. Coeur Med Interne (1978) 0.75
[Ambulatory monitoring of blood pressure in orthostatic hypotension of Parkinson disease]. Rev Neurol (Paris) (1993) 0.75
Adrenoceptors in the diagnosis of phaeochromocytoma. Lancet (1987) 0.75
[Arterial hypertension and insulin resistance]. Lik Sprava (1997) 0.75
[Renal insufficiency and treatment of persistent cardiac insufficiency with converting enzyme inhibitor]. Therapie (1989) 0.75
An attempt to improve blood pressure control in the French population: information and outcome awareness at the general practitioner level. Am J Hypertens (1998) 0.75
[Influence of absolute risk and sex on the treatment of arterial hypertension in Haute-Garonne]. Arch Mal Coeur Vaiss (1999) 0.75
[Resuscitation of hemorrhagic shock in cirrhotics taking propranolol]. Gastroenterol Clin Biol (1985) 0.75
[Hypertension in 45 females on oral contraceptives]. Rev Med Interne (1980) 0.75
[Primary biliary cirrhosis associated with autoimmune thrombopenic purpura and pleuropericarditis]. Gastroenterol Clin Biol (1987) 0.75
[Value of the study of electrocardiographic P wave in pheochromocytoma]. Arch Mal Coeur Vaiss (1992) 0.75
[Glomerular and tubular renal disease in primary biliary cirrhosis]. Gastroenterol Clin Biol (1991) 0.75
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study]. Ann Med Interne (Paris) (1995) 0.75
[Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism]. Arch Mal Coeur Vaiss (1987) 0.75
[Corynebacterium (JK group) endocarditis. Apropos of a case]. Sem Hop (1984) 0.75
[Long-term development of blood pressure profile in hypertensive hemodialysis patients]. Arch Mal Coeur Vaiss (2002) 0.75
[Influence of cardiovascular risk factors on prescribing of antihypertensives]. Arch Mal Coeur Vaiss (2001) 0.75
[A study of antithrombin systems during heparin therapy]. Nouv Presse Med (1982) 0.75
Plasma levels of aldosterone versus aldosterone precursors: a way to estimate the malignancy of asymptomatic and nonsecretory adrenal tumors: a French Retrospective Multicentric Study. J Clin Endocrinol Metab (1995) 0.75
Plasma antithrombins during heparin therapy. Thromb Res (1982) 0.75
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)]. Ann Med Interne (Paris) (1996) 0.75
[Role of the TRF test in the study of atrial dysrhythmia]. Rev Med Interne (1983) 0.75
Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists. Clin Exp Hypertens A (1987) 0.75
[Mediacalcosis and pseudo-arterial hypertension in diabetics: value of the Osler maneuver]. Rev Med Interne (1989) 0.75
[Ambulatory blood pressure, intima media thickness, global cardiovascular risk and therapeutic decisions]. Arch Mal Coeur Vaiss (1998) 0.75
[Primary and idiopathic hyperaldosteronism. Course 1 year after operation. Apropos of 28 cases]. Arch Mal Coeur Vaiss (1976) 0.75
[Electrocardiogram in primary and idiopathic hyperaldosteronism. Apropos of 42 cases]. Rev Med Interne (1981) 0.75
[Rheumatologic aspects of toxocariasis (visceral Larva migrans). Apropos of 2 cases]. Rev Rhum Ed Fr (1993) 0.75
Relationships between blood pressure components, lipids and lipoproteins in normotensive men. J Hum Hypertens (1996) 0.75
[For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden?]. Rev Prat (1992) 0.75
[Treatment of arterial hypertension in the diabetic]. Presse Med (2000) 0.75
[Cardiotoxicity and immunomodulators: apropos of a case]. Therapie (2000) 0.75
Association of eNOS Glu298Asp gene polymorphism with circadian blood pressure rhythm. J Hum Hypertens (2007) 0.75
Platelet sodium-proton exchange rates in young adults with a history of childhood hypertension. J Hypertens Suppl (1991) 0.75
[Amyloid cardiopathy disclosing Waldenström's macroglobulinemia]. Presse Med (1983) 0.75
[Multifocal osteonecrosis and cholesterol crystal embolism]. Rev Rhum Ed Fr (1993) 0.75
[Influence of global cardiovascular risk assessment on the management of hypertension in southwestern France]. Arch Mal Coeur Vaiss (1998) 0.75
[Arterial blood pressure changes, circadian rhythm and arterial elasticity in hemodialysed patients]. Arch Mal Coeur Vaiss (1994) 0.75